Shopping Cart
- Remove All
- Your shopping cart is currently empty
KW-8232 free base can reduces the biosynthesis of PGE2, is an anti-osteoporotic agent.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | KW-8232 free base can reduces the biosynthesis of PGE2, is an anti-osteoporotic agent. |
In vitro | KW-8232 reduces the biosynthesis of PGE2 in mouse osteoblastic cells.KW-8232 free base is an anti-osteoporotic agent. |
In vivo | KW-8232 markedly decreases urinary calcium excreation in the neurectomized rats only at 30 mg/kg, and highly reduces urinary pyridinoline and deoxypyridionline excretion which are markers of bone resorption in neurectomized rats. KW-8232 inhibits bone loss may be attributed to the lower prostaglandins (PGs)-stimulated bone resorption via regulation of PGE2 production.KW-8232 (3, 10, 30 mg/kg, p.o.) potently increases the femoral bone mineral density (BMD) of immobilized legs of rats, and affects immobilization-induced abnormal bone turnovrer. |
Molecular Weight | 609.16 |
Formula | C36H37ClN4O3 |
Cas No. | 170365-25-0 |
Relative Density. | 1.26 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.